Living Donor Liver Transplantation in PSC Patients Giuliano Testa, MD, FACS, MBA Surgical Director, Living Donor Liver Transplantation Baylor University.

Slides:



Advertisements
Similar presentations
CURRENT STATE OF LIVER ALLOCATION AND DISTRIBUTION John R. Lake, MD University of Minnesota Medical School.
Advertisements

Operating on patient with Hepatitis C Sonal Asthana, MD and Norman Kneteman, MD Can J Surg August; 52(4): 337–342. Canadian Journal of Surgery The.
SRTR Transplant Benefit-Based Liver Allocation Robert M. Merion, MD, FACS OPTN/UNOS Liver Forum Atlanta, GA April 12, 2010.
An update on liver transplantation Joint Hospital Surgical Grand Round 19/7/2014.
Risё Stribling, MD Medical Director of Liver Transplant St Luke’s Medical Center Associate Professor of Surgery Baylor College of Medicine.
Hepatitis web study H EPATITIS C C URRICULUM Terry D. Box, MD Associate Professor of Medicine Division of Gastroenterology/Hepatology University of Utah.
Northwestern University Feinberg School of Medicine New Trends in organ donation and Transplantation Juan Carlos Caicedo, MD FACS Director, Hispanic Transplant.
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index American Journal of Transplantation 2006; 6: 783–790 S. Fenga, N.P.
Interventional Oncology Michael Kotton MD October 27, 2012.
ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results.
The Recipient Experience Jaime Myers, RN, MSN, CCTC April 29, 2011.
Liver Cirrhosis S. Diana Garcia
MEDICAL ASPECTS OF LIVING KIDNEY DONATION Introduction:  Kidney Tx cannot Proceed without donor.  Appropriate identification & preparation of the donors.
An International Case Study of Lung Transplantation
Kidney Transplant: A Realistic Chance for Elderly Patients Reference: Munnapradist S, Danovitch GM. Kidney transplants for the elderly: Hope or hype? Clin.
Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths
+ Liver Transplantation for PSC Patients A Transplant Surgeon’s Perspective Tiffany Anthony, MD Annette C. and Harold C. Simmons Transplant Institute Baylor.
Proposal to Delay the HCC Exception Score Assignment (Resolution 9) Liver and Intestine Committee David Mulligan, Chair November 12 and 13, 2014.
FT in prognostic of HBV FibroTest: predictive value in HBV.
Hepatitis C+ Recipients: Considerations for Exclusion Emily A. Blumberg, M.D.
Liver transplant: myths and realities James Trotter, MD Baylor University Medical Center Dallas, Texas.
Liver and Intestinal Organ Transplantation Committee Update Report David Mulligan, MD, Chair OPTN/UNOS Board of Directors Meeting November 12-13, 2014.
Andreas A. Rostved, MD Research assistant Department of Surgical Gastroenterology and Transplantation Rigshospitalet – Copenhagen University Hospital Denmark.
Transplantation in HIV Michelle Roland, MD Assistant Professor of Medicine UCSF Positive Health Program at SFGH.
IMPROVING CONSENT VIA PATIENT SUPPORT GROUPS King Faisal Specialist Hospital & Research Center - Jeddah Yaser M Kattoah - Administrative Transplant Coordinator.
A2ALL When Using A2ALL Slides We welcome the use of A2ALL slides, as we value the distribution of our research for the benefit of patient care and transplant.
Trends in Treatment of Recurrent Hepatitis C After Liver Transplantation Kate Forgan-Smith KA Stuart 1,4, C Tallis 1,4 GA Macdonald 1,3,4, J Fawcett 2,3.
Liver transplantation for HCV infection R3 양 인 호 /Prof 김 병 호.
Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer in the Elderly: A Population-Based Study in Ontario, Canada JOURNAL OF CLINICAL ONCOLOGY, VOLUME 30.
소화기내과 김경엽 Gastroenterology 2011;140:
Rapid Fibrosis and Significant Histologic Recurrence of Hepatitis C After Liver Transplant Is Associated With Higher Tumor Recurrence Rates in Hepatocellular.
Liver Transplantation in PSC: What to Know and Recent Updates Brett E. Fortune, MD, MSc Assistant Professor of Medicine and Surgery Yale School of Medicine.
Cadaveric vs Living Donation; Comparing Options
Acute Liver Failure Anand Annamalai.
James S. Tweddell, MD Warren W. Bailey Endowed Chair,
11/11/16 Kirstie Wallace/Hazel Muse Transplant Co-ordinators
Hepatocellular Carcinoma: Diagnosis and Management
National Hepatitis C Database
Liver Transplantation – ‘who needs a liver transplant’
Volume 150, Issue 2, Pages e6 (February 2016)
Liver transplantation and PSC
The Recipient Experience
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
HCV & liver transplantation
New insights in the natural history of PSC
Liver Transplantation: 50 years
Successful TACE for HCC
Outline.
Liver Transplant For Patients with PSC
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
EUROPEAN LIVER TRANSPLANT REGISTRY
Jayant A. Talwalkar, MD, MPH, Patrick S. Kamath, MD 
Changes to HCC Criteria for Auto Approval
Living donor liver transplantation: is the hype over?
Recent Advances in Liver Transplantation
Roberts Brown, Jean C. Emond  Gastroenterology 
Alcoholic liver disease in intensive care
Volume 124, Issue 1, Pages (January 2003)
Liver cancer: Approaching a personalized care
Trends in the management and burden of alcoholic liver disease
Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States  Ju Dong Yang, Joseph.
Proposal to Delay the HCC Exception Score Assignment
Assistant professor of Hepatology Alexandria University
Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease  Sandra Amaral, Blayne A.
Volume 143, Issue 5, Pages (November 2012)
Jordi Bruix, Maria Reig, Morris Sherman  Gastroenterology 
Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer  Edoardo Giannini, Federica Botta,
Donor Allocation Policy in the US
Outcomes in liver transplantation: Does sex matter?
Presentation transcript:

Living Donor Liver Transplantation in PSC Patients Giuliano Testa, MD, FACS, MBA Surgical Director, Living Donor Liver Transplantation Baylor University Medical Center Annette C. and Harold C. Simmons Transplant Institute

Donor Age (rarely 55-60) Perfect physical and mental health Appropriate Liver Volume & Anatomy (% resection less important than RDV/DW ratio or SLV) Emotional connection

Patients with: Intractable ascites Encephalopathy Recurrent variceal bleeding HCC over UNOS criteria Cholestatic liver disease In general, all patients with established cirrhosis, low MELD, and a severely diminished quality of life LivingDonorLiverTransplant Who are the best candidates?

Why Living Donor Liver Transplantation? In fact, the magnitude of mortality reduction was among the largest observed with any form of transplant intervention A2ALL Study Group Gastroenterology 2007, Pages

How living donor liver transplant changes the scenario It offers an opportunity to patients who: have a little chance of receiving a cadaver liver transplant because they are “not sick enough” do not qualify for cadaver liver transplant because of the nature of their liver disease (hepatocellular carcinoma, polycystic liver disease, etc.) LivingDonorLiverTransplant

Why Living Donor Liver Transplant? Chronic lack of suitable deceased donors (only number increase in less quality organs) Increasing MELD at transplantation Tangible benefits for the recipients and for the transplant program

Rest Volume (ml) Regeneration 3 Months Mean Regeneration n= Volumetric and Functional Recovery of the Liver After Right Hepatectomy for Living Donation Liver Transplantation, Vol 10, No 8 (August), 2004: pp 1024–1029 Silvio Nadalin, Giuliano Testa, Massimo SMalago´, Mechtild Beste, Andrea Frilling, Thobias Schroeder, Christoph Jochum, Guido Gerken, and Christoph E. Broelsch

Donor Blood work and ABO MRCP/MRA Donor Advocate Team (Social Worker, Hepatologist, Donor Advocate Physician) Liver biopsy

Is living donor liver transplantation an option? When is living donor liver transplantation indicated? What is the expected outcome after living donor liver transplantation?

When is living donor liver transplant indicated? Anytime liver transplant is indicated Anytime the recipient can be a candidate for a living donor liver transplant and a donor is stepping forward

What will make a patient not a candidate for a living donor liver transplant? poor renal function size

What is and when is living donor liver transplantation indicated?

Insert slides regarding living donor liver transplantation

Transplant when? Quality of life Survival Risk of cancer

Quality of life For some is not an indication to proceed to LTX* Decision taking into consideration: immediate risk; lifelong need for immunosuppression; risk of recurrence In my opinion, each case should be individually judged * Tamura S, World Journal of Gastroenterology, 2008

Survival Decision can be based on crude MELD score; for some centers MELD >15 When the risk of death by natural disease course is predicted to outweigh the risk of death of liver transplant Natural History: median survival form diagnosis 12 years* In my opinion, MELD alone should not be the decisive factor * Wiesner RH, Hepatology 1989

MELD does not correctly reflect the degree of illness in PSC patients (often very high bilirubin not accompanied by parallel increase in creatinine/INR)

Risk of Cancer Reported between 6% to 36% of patients Cancer significantly changes outcome Cohort of 171 patients, 25 (15%) developed CCC 7/25 underwent transplantation In my opinion: the occurrence of new dominant stricture / change in existing stricture should prompt evaluation for LTX Goldberg DS, Liver Transplantation 2013; Goldberg DS, Transplantation 2011

1 year 97.2% 3 years 95.4% 5 years 87.5% Same/better than deceased donor liver transplant Kashyap RJ, Gastrointest Surg 2010

Wait times to LTX are longer for pts with PSC and became longer after MELD introduction* PSC pts are more likely to receive an LDLT* Lower risk of graft failure for LDLT vs LTX* * Goldberg DS, Transplantation 2011; Goldberg DS, Hepatology 2014